✦ LIBER ✦

Removal notice to “Nimotuzumab in combination with docetaxel and carboplatin as treatment for advanced non-small-cell-lung-cancer” EJC Supp 9 (2011) 23

✍ Scribed by D. Qi; Q. Wang; C. Huang; Y. Li; Y. Yang; Y. Cui; L. Xin; J. Xu; H. Wang; J. Zheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

REMOVED: P57 NIMOTUZUMAB IN COMBINATION

✍ D. Qi; Q. Wang; C. Huang; Y. Li; Y. Yang; Y. Cui; L. Xin; J. Xu; H. Wang; J. Zhe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 17 KB

A phase I/randomized phase II, non-compa

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

6508 ORAL CP-751, 871, an anti-IGF-IR an

✍ Paz-Ares, L.; Pollak, M.N.; Eisenberg, P.D.; Blakely, L.J.; Haluska, P.; Cohen, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

PD-147 A phase I study of a second gener

✍ Laskin, J.; Chi, K.; Melosky, B.; Sill, K.; Hao, D.; Canil, C.; Gleave, M.; Murr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB